The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended....Sales and Promotional Services Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Pennsylvania
This Sales and Promotional Services Agreement (this “Agreement”) effective as of October 1, 2010 (the “Effective Date”) is entered into by and between VENTIV COMMERCIAL SERVICES, LLC, a New Jersey limited liability company (“VCS”), and ENDO PHARMACEUTICALS INC., a Delaware corporation (“CLIENT”). VCS and CLIENT are sometimes referred to herein collectively as the “Parties,” and individually as a “Party.”
PLEDGE AND SECURITY AGREEMENTPledge and Security Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
THIS PLEDGE AND SECURITY AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time, this “Security Agreement”) is entered into as of November 30, 2010 by and among ENDO PHARMACEUTICALS HOLDINGS INC., a Delaware corporation (the “Borrower”), the Subsidiaries of the Borrower listed on the signature pages hereto (together with the Borrower, the “Initial Grantors,” and together with any additional Material Domestic Subsidiaries, whether now existing or hereafter formed or acquired which become parties to this Security Agreement from time to time, in accordance with the terms of the Credit Agreement (as defined below), by executing a Supplement to Pledge and Security Agreement hereto in substantially the form of Annex I, the “Grantors”), and JPMORGAN CHASE BANK, N.A., a national banking association, in its capacity as administrative agent (the “Administrative Agent”) for itself and for the Secured Parties (as defined in the Credit Agreement identi
CREDIT AGREEMENT dated as of November 30, 2010 among ENDO PHARMACEUTICALS HOLDINGS INC. The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent ROYAL BANK OF CANADA as Syndication Agent and BARCLAYS BANK PLC as Documentation AgentCredit Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of November 30, 2010 among ENDO PHARMACEUTICALS HOLDINGS INC., the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, ROYAL BANK OF CANADA, as Syndication Agent and BARCLAYS BANK PLC, as Documentation Agent.
FORM OF ENDO PHARMACEUTICALS HOLDINGS INC. ENDO STOCK AWARD AGREEMENT UNDER THE 2010 STOCK INCENTIVE PLANEndo Stock Award Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This Endo Stock Award Agreement (this “Award Agreement”), is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Endo Pharmaceuticals Holdings Inc. 2010 Stock Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
Amendment to Supply AgreementSupply Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
This Amendment dated January 16, 2007 is made by and between Noramco, Inc., a Georgia Corporation with its principle office at 500 Swede’s Landing Road, Wilmington, Delaware 19801 and its Affiliates (“NORAMCO”), Vintage Pharmaceuticals, LLC, and Vintage Pharmaceuticals, Inc., an Alabama corporation with its principle office at 130 Vintage Drive, Huntsville Alabama 35811 and its Affiliates (“VINTAGE”).
Amendment to Supply AgreementSupply Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
This Third Amendment dated December 22, 2008, is made by and between Noramco, Inc., a Georgia Corporation with its principal office at 500 Swedes Landing Road, Wilmington, Delaware 19801 and its Affiliates (“NORAMCO”) and Vintage Pharmaceuticals, LLC, a Delaware corporation with its principal office at 130 VINTAGE Drive, Huntsville, Alabama 35811 and its Affiliates (“VINTAGE”).
FORM OF ENDO PHARMACEUTICALS HOLDINGS INC. STOCK OPTION AGREEMENTStock Option Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This Stock Option Agreement (the “Option Agreement”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo Pharmaceutical Holdings Inc., a Delaware corporation (the “Company”), and the optionee named below (the “Optionee”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2010 Stock Incentive Plan (the “Plan”).
Amendment to Supply AgreementSupply Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
This Amendment dated May 7, 2008 is made by and between Noramco, Inc., a Georgia Corporation with its principle office at 500 Swede’s Landing Road, Wilmington, Delaware 19801 and its Affiliates (“NORAMCO”) and Vintage Pharmaceuticals, Inc., an Alabama corporation with its principle office at 130 Vintage Drive, Huntsville Alabama 35811 and its Affiliates (“VINTAGE”).
SUPPLY AGREEMENTSupply Agreement • February 28th, 2011 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New Jersey
This Agreement made by and between VINTAGE PHARMACEUTICALS, INC., an Alabama corporation (hereinafter “VINTAGE”) and NORAMCO, a division of McNeilab, Inc., a Pennsylvania corporation (hereinafter “NORAMCO”).
